Pineridge Advisors »

Aldeyra Therapeutics shares owned by Pineridge Advisors

Quarter-by-quarter ownership of Aldeyra Therapeutics (ALDX) shares owned by Pineridge Advisors from 13F filings

Historical chart of Pineridge Advisors investment in Aldeyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aldeyra Therapeutics held by Pineridge Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aldeyra Therapeutics by Pineridge Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.1k 600 5.22

More positions owned by Pineridge Advisors

Bondbloxx Etf Trust Bloomberg Six Mn (XHLF)
Ishares Tr Core S&p Ttl Stk (ITOT)
Bondbloxx Etf Trust Bloomberg Fve Yr (XFIV)
Goldman Sachs Etf Tr S&p 500 Premium (GPIX)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Bondbloxx Etf Trust Bloomberg Seven (XSVN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Ibonds 28 Trm Ts (IBTI)
Spdr Series Trust Portfolio Short (SPSB)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Microsoft Corporation (MSFT)
Bondbloxx Etf Trust Ir M Taxaware (TAXX)
Ishares Tr Shrt Nat Mun Etf (SUB)
Ishares Tr Core S&p500 Etf (IVV)

View all positions for Pineridge Advisors

Top funds holding Aldeyra Therapeutics

Knoll Capital Management
Perceptive Advisors
BlackRock
Vanguard Group
Ardsley Advisory Partners
AQR Capital Management
D. E. Shaw & Co
Kingdon Capital Management
Geode Capital Management
Kennedy Capital Management
State Street Corporation
Jacobs Levy Equity Management
Acadian Asset Management
683 Capital Management
Morgan Stanley

View all funds holding Aldeyra Therapeutics